SEC Form 4 · accession 0001127602-16-055849
PDS Biotechnology Corp · PDSB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Renu Vaish
Officer — V.P., Global Reg. Affairs
Period of report
Jun 16, 2016
Accepted (ET)
Jun 20, 2016 · 11:51 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001472091
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 16, 2016 | M | 5,000 | $5.13 | A | 5,350 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right To Purchase)F1 | $5.13 | Jun 16, 2016 | M | 5,000 | D | — | Jan 5, 2025 | Common Stock | 5,000 | 115,605 | D |
Explanation of responses
- F1This option, representing a right to purchase a total of 120,605 shares of Common Stock, will become exercisable on January 5, 2016, with 25% vesting on that date and 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date.